Targeting chk2 kinase: molecular interaction maps and therapeutic rationale

Area of Science:

• Molecular biology
• Cancer research
• Cell signaling

Background:

• Most anticancer drugs target genomic DNA, relying on tumor-specific defects for selectivity.
• The ATM-Chk2 pathway plays a critical role in DNA damage response, cell cycle checkpoints, and apoptosis.

Purpose of the Study:

• To review molecular interactions within the ATM-Chk2 pathway.
• To discuss the pathway's redundancy and functional roles.
• To explore Chk2 inhibitors for enhancing anticancer drug selectivity and treating specific tumors.

Main Methods:

• Review of molecular interactions using the Molecular Interaction Map (MIM) convention.
• Analysis of pathway redundancy and substrate phosphorylation.
• Survey of existing Chk2 inhibitors and proposal of novel screening methods.

Main Results:

• The ATM-Chk2 pathway exhibits redundancy, with ATM and Chk2 phosphorylating common substrates.
• Multiple kinases (Chk2, Chk1, Plk's) can phosphorylate similar substrate residues.
• Chk2 activation influences apoptosis and cell cycle checkpoints via various downstream effectors.

Conclusions:

• Chk2 inhibitors offer a potential strategy to improve the tumor selectivity of DNA-targeting anticancer agents.
• Targeting Chk2 may be beneficial for treating tumors with specific dependencies on its activity, particularly in p53-deficient contexts.